João Pedro Rodrigues

Prof. João Pedro Rodrigues

Universidade Federal do Ceara
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
JSJorge Ederson Gonçalves Santana
Jorge Ederson Gonçalves Santana
GAGabriel Gonçalves Alencar
Gabriel Gonçalves Alencar
GSGustavo Miguel Siqueira
Gustavo Miguel Siqueira
SGSheila Alves Gonçalves
Sheila Alves Gonçalves
HCHenrique Coutinho
Henrique Coutinho
Valencene and nootkatone are aromatic sesquiterpenes with known biological activities, such as antimicrobial, antioxidant, anti-inflammatory, and antitumor. Given the evidence that encapsulation into nanosystems, such as liposomes, could improve the properties of several compounds, the present study aimed to evaluate the activity of these sesquiterpenes in their isolated state or in liposomal formulations against strains of Staphylococcus aureus carrying efflux pumps. The broth microdilution method evaluated the antibiotic-enhancing activity associated with antibiotics and ethidium bromide (EtBr). The minimum inhibitory concentration was assessed in strains of S. aureus 1199B, IS-58, and RN4220, which carry the efflux proteins NorA, Tet(K), and MsrA. In tests with strain 1199B, valencene reduced the MIC of norfloxacin and EtBr by 50%, while the liposomal formulation of this compound did not show a significant effect. Regarding the strain IS-58, valencene, and its nanoformulation reduced norfloxacin MIC by 60.3% and 50%, respectively. In the non-liposomal form, the sesquiterpene reduced the MIC of EtBr by 90%. Against the RN4220 strain, valencene reduced the MIC of the antibiotic and EtBr by 99% and 93.7%, respectively. Nootkatone and its nanoformulation showed significant activity against the 1199B strain, reducing the EtBr MIC by 21.9%. Against the IS-58 strain, isolated nootkatone reduced the EtBr MIC by 20%. The results indicate that valencene and nootkatone potentiate the action of antibiotics and efflux inhibitors in strains carrying NorA, Tet(K), and MsrA proteins, which suggests that these sesquiterpenes act as efflux pump inhibitors in S. aureus. Therefore, further studies are needed to assess the impact of incorporation into liposomes on the activity of these compounds in vivo.

17 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JSJorge Ederson Gonçalves Santana
Jorge Ederson Gonçalves Santana
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
GAGabriel Gonçalves Alencar
Gabriel Gonçalves Alencar
GSGustavo Miguel Siqueira
Gustavo Miguel Siqueira
DADaniel Sampaio Alves
Daniel Sampaio Alves
TGTeresinha Gonçalves-Silva
Teresinha Gonçalves-Silva
The efflux systems are considered important mechanisms of bacterial resistance due to their ability to extrude various antibiotics. Several naturally occurring compounds, such as sesquiterpenes, have demonstrated antibacterial activity and the ability to inhibit efflux pumps in resistant strains. Therefore, the objective of this research was to analyze the antibacterial and inhibitory activity of the efflux systems NorA, Tet(K), MsrA, and MepA by sesquiterpenes nerolidol, farnesol, and α-bisabolol, used either individually or in liposomal nanoformulation, against multi-resistant Staphylococcus aureus strains. The methodology consisted of in vitro testing of the ability of sesquiterpenes to reduce the Minimum Inhibitory Concentration (MIC) and enhance the action of antibiotics and ethidium bromide (EtBr) in broth microdilution assays. The following strains were used: S. aureus 1199B carrying the NorA efflux pump, resistant to norfloxacin; IS-58 strain carrying Tet(K), resistant to tetracyclines; RN4220 carrying MsrA, conferring resistance to erythromycin. For the EtBr fluorescence measurement test, K2068 carrying MepA was used. It was observed the individual sesquiterpenes exhibited better antibacterial activity as well as efflux pump inhibition. Farnesol showed the lowest MIC of 16.5 µg/mL against the S. aureus RN4220 strain. Isolated nerolidol stood out for reducing the MIC of EtBr to 5 µg/mL in the 1199B strain, yielding better results than the positive control CCCP, indicating strong evidence of NorA inhibition. The liposome formulations did not show promising results, except for liposome/farnesol, which reduced the MIC of EtBr against 1199B and RN4220. Further research is needed to evaluate the mechanisms of action involved in the inhibition of resistance mechanisms by the tested compounds.

2 April 2021 in Cosmetics
Verified
Journal Article
Open access
PDF file
CBCamila Fonseca Bezerra
Camila Fonseca Bezerra
JJJosé Geraldo de A. Júnior
José Geraldo de A. Júnior
RHRosilaine de L. Honorato
Rosilaine de L. Honorato
ASAntonia Thassya L. dos Santos
Antonia Thassya L. dos Santos
JSJosefa Carolaine P. da Silva
Josefa Carolaine P. da Silva
TGTeresinha Gonçalves-Silva
Teresinha Gonçalves-Silva
Fungal pathologies caused by the genus Candida have increased in recent years due to the involvement of immunosuppressed people and the advance of resistance mechanisms acquired by these microorganisms. Liposomes are nanovesicles with lipid bilayers in which they store compounds. α-Bisabolol is a sesquiterpene with proven biological activities, and in this work it was tested alone in liposomes and in association with Fluconazole in vitro to evaluate the antifungal potential, Fluconazole optimization, and virulence inhibitory effect in vitro. Antifungal assays were performed against standard strains of Candida albicans, Candida tropicalis, and Candida krusei by microdilution to identify the IC50 values and to obtain the cell viability. The Minimum Fungicidal Concentration (MFC) was performed by subculturing on the solid medium, and at their subinhibitory concentration (Matrix Concentration (MC): 16,384 µg/mL) (MC/16), the compounds, both isolated and liposomal, were associated with fluconazole in order to verify the inhibitory effect of this junction. Tests to ascertain changes in morphology were performed in microculture chambers according to MC concentrations. Liposomes were characterized from the vesicle size, polydispersity index, average Zeta potential, and scanning electron microscopy. The IC50 value of the liposomal bisabolol associated with fluconazole (FCZ) was 2.5 µg/mL against all strains tested, revealing a potentiating effect. Liposomal bisabolol was able to potentiate the effect of fluconazole against the CA and CT strains by reducing its concentration and completely inhibiting fungal growth. α-Bisabolol in liposomal form inhibited the morphological transition in all strains tested at a concentration of MC/8. The liposomes were homogeneous, with vesicles with diameters of 203.8 nm for the liposomal bisabolol and a surface charge potential of −34.2 mV, conferring stability to the nanosystem. Through scanning microscopy, the spherical shapes of the vesicles were observed.

27 January 2022 in Journal of Food Processing and Preservation
Verified
Journal Article
Closed access
PDF file
EOErivan de Souza Oliveira
Erivan de Souza Oliveira
MLMighay Lovera
Mighay Lovera
VPValessa Rios Pires
Valessa Rios Pires
FMFrancisco Rogenio da Silva Mendes
Francisco Rogenio da Silva Mendes
NMNadya Virginia Lima Peixoto Maia
Nadya Virginia Lima Peixoto Maia
AMAna Cristina Monteiro-Moreira
Ana Cristina Monteiro-Moreira

1 October 2025 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
VMVANESSA BARBOSA PINHEIRO Ap Maisa
VANESSA BARBOSA PINHEIRO Ap Maisa
GMGabriel Acácio de Moura
Gabriel Acácio de Moura
JRJoão Pedro Rodrigues
João Pedro Rodrigues
JLJavier Martinez Latorre
Javier Martinez Latorre
VNVicente Candela Noguera
Vicente Candela Noguera
RNRoberto Nicolete
Roberto Nicolete
Background: The use of bioactive molecules isolated from rattlesnake venom and other poisons has been ongoing for years. Among these bioactive compounds present in snake venom, crotoxin (CTX) stands out as a β-heterodimeric neurotoxin isolated from the venom of Crotalus durissus terrificus. Research on this toxin for its applicability to tumor inhibition has advanced to clinical trials in recent years. Consequently, concerns regarding the use of a toxin as a treatment and the search for dose control that does not trigger extreme toxicity have emerged. Thus, it is necessary to investigate alternatives for controlled delivery and targeted toxin administration. Methods: This study aimed to evaluate the in vitro toxic action of CTX and its phospholipase A2 CB (PLA2CB) component, both free and encapsulated in polymeric nanoparticles. The inhibitory concentration value of 50% tumor growth (IC50) for CTX and PLA2CB was determined in an initial screening against six tumor cell lines. After identifying the lowest inhibitory concentration value of 0.8 μM observed in human melanoma (SK-MEL-103), this cell line was chosen. Results: The cell death mechanism triggered by CTX and PLA2CB exhibited characteristics associated with the necrotic process. However, polymeric nanoparticles containing PLA2CB (NP-PLA2CB) demonstrated apoptosis-like cell death processes in flow cytometry. PLGA polymeric nanoparticles containing PLA2CB were synthesized using microfluidics, resulting in NP-PLA2CB with a diameter of 91 ± 2.9 nm and a zeta potential of -21.8 ± 3.2 mV. The encapsulation efficiency of PLA2CB was approximately 70% (protein content). Conclusion: It was concluded that using the phospholipase component of the toxin in a polymeric-controlled delivery and targeted system may be an alternative solution to the issues in advancing this bioactive molecule in clinical-oncological studies. However, further studies are still being conducted for targeted treatment involving this nanotechnological approach.

13 February 2024
Verified
Preprint
Open access
PDF file
JRJoão Pedro Rodrigues
João Pedro Rodrigues
* Integrate a more comprehensive review of existing literature to situate the study within the current knowledge base, highlighting its novel contributions and how it addresses gaps in the field; * Enhance the clarity and detail of the experimental...